Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Subjects
Article Type
Date
Availability
1-3 of 3
Keywords: chemotherapy resistance
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Journal:
Bioscience Reports
Biosci Rep (2024) 44 (7): BSR-2019-0946_RET.
Published: 12 July 2024
... © 2024 The Author(s). 2024 This is an open access article published by Portland Press Limited on behalf of the Biochemical Society and distributed under the Creative Commons Attribution License 4.0 (CC BY) . cell proliferation chemotherapy resistance DEPDC1 hepatocellular carcinoma...
Articles
Journal:
Bioscience Reports
Biosci Rep (2019) 39 (7): BSR20190946.
Published: 10 July 2019
... on HCC cell viability and chemotherapy resistance. Conclusion: Collectively, our data may provide some evidence for DEPDC1 as a candidate therapeutic target for HCC. Hepatocellular carcinoma, one of the most prevalent human malignancies, ranks the third most leading cause of tumor-related mortality...
Articles
Journal:
Bioscience Reports
Biosci Rep (2018) 38 (6): BSR20180595.
Published: 07 December 2018
... cytometry (BD Biosciences). Breast cancers Cancer stem cells Chemotherapy resistance Tamoxifen Vitamin D receptor Breast cancer is the second most common malignancy in women, and accounts for almost 30% of new cancers and 15% of cancer-related deaths [ 1 , 2 ]. Breast cancer...
